This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Fusidic acid

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Fusidic acid is a narrow spectrum antibiotic with a steroid like structure which prevents the translocation step of bacterial peptide synthesis by inhibiting factor G.

Its only indication is infections due to penicillin resistant Staphylococci, especially osteomyelitis since fusidic acid is concentrated in bone. A second antistaphylococcal agent is also required to prevent the development of resistance.

Cautions:

  • liver function tests required

Side-effects:

  • rashes
  • reversible jaundice
  • nausea and vomiting

Routes of administration:

  • oral:
    • tablets
    • suspension
  • i.v. infusion

Note that topical preparations of fusidic acid are also available:

  • fusidic acid eye drops - useful treatment for staphylococcal superficial eye infections
  • fusidic acid (in the form of ointment or cream) is available for the treatment of staphylococcal skin infections; preparations of fusidic acid combined with a topical steroid is a useful agent for treatment of infected eczema/dermatitis

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.